Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F (Q79940087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

chronic idiopathic myelofibrosis

1 reference

Shide K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Shimoda HK

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kumano T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Karube K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kameda T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Takenaka K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Oku S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Abe H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Katayose KS

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kubuki Y

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kusumoto K

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hasuike S

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tahara Y

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nagata K

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Matsuda T

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ohshima K

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Harada M

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Shimoda K

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

22 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

87-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18033315%20AND%20SRC:MED&resulttype=core&format=json

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Jak2 is essential for signaling through a variety of cytokine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Cytokine receptor signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

STATs: signal transducers and activators of transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Jaks and Stats in cytokine signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

The significance of endogenous erythroid colonies (EEC) in haematological disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Characterization of murine JAK2V617F-positive myeloproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Chromosomal mapping and zygosity check of transgenes based on flanking genome sequences determined by genomic walking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405043

7 January 2021